4.6 Review

Linking Diabetes to Alzheimer's Disease: Potential Roles of Glucose Metabolism and Alpha-Glucosidase

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pharmacology & Pharmacy

Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales

Amelia D. Dahlen et al.

Summary: Type 2 diabetes mellitus is a significant medical problem due to its increasing global prevalence and its connection with obesity, liver disease, and cardiovascular diseases. There are now nearly 60 FDA-approved drugs and nearly 100 others being evaluated in clinical trials for the treatment of T2DM. Modern drugs, such as GLP-1 receptor agonists and SGLT2 inhibitors, are gaining popularity on the pharmaceutical market.

FRONTIERS IN PHARMACOLOGY (2022)

Article Biochemistry & Molecular Biology

Repositioning of antidiabetic drugs for Alzheimer's disease: possibility of Wnt signaling modulation by targeting LRP6 an in silico based study

Suman Manandhar et al.

Summary: Alzheimer's disease is a common and progressive form of dementia, and research suggests that antidiabetic medications may have a beneficial effect on the disease through modulation of the Wnt signaling pathway, but further experimental studies are needed for verification.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)

Article Neurosciences

Dietary sugar intake and risk of Alzheimer's disease in older women

Longjian Liu et al.

Summary: This study found a significant association between excessive total sugar intake and AD risk in women, with lactose showing a stronger impact on AD risk.

NUTRITIONAL NEUROSCIENCE (2022)

Article Biochemistry & Molecular Biology

Caspase-cleaved tau is senescence-associated and induces a toxic gain of function by putting a brake on axonal transport

Christian Conze et al.

Summary: Tau protein plays a central role in diseases like Alzheimer's, and its function can be affected by cellular senescence. In this study, researchers found that a specific form of tau protein (TauC3) is increased in senescent mice and AD patients. This modified tau protein has reduced dynamics in interacting with microtubules, which leads to defects in axonal transport and neuronal degeneration. The microtubule-targeting drug Epothilone D can normalize this interaction and modulate transport processes. These findings suggest the potential of using microtubule-targeting drugs to restore the physiological function of tau protein.

MOLECULAR PSYCHIATRY (2022)

Review Behavioral Sciences

The role of glucose in cognition, risk of dementia, and related biomarkers in individuals without type 2 diabetes mellitus or the metabolic syndrome: A systematic review of observational studies

Mariam Kirvalidze et al.

Summary: This systematic review explores the association between blood glucose levels and cognition, dementia risk, and related biomarkers in adults without diabetes or metabolic syndrome. The results suggest that higher blood glucose may contribute to dementia-related neuropathology, but the impact on cognitive decline or dementia risk later in life remains unclear.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2022)

Review Chemistry, Multidisciplinary

Inhibition of Insulin Degrading Enzyme to Control Diabetes Mellitus and its Applications on some Other Chronic Disease: a Critical Review

Md. Shofiul Azam et al.

Summary: This review provides insights into the insulin-degrading enzyme (IDE) and its association with type 2 diabetes (T2D), Alzheimer's disease (AD), obesity, and cardiovascular diseases. Molecular docking analysis reveals that IDE plays a crucial role in breaking down pathophysiologically important extracellular substrates, including amyloid beta-protein (A beta) and insulin, and dysregulation of IDE is linked to the development of AD and T2D. The review also summarizes the factors regulating insulin reformation by IDE and highlights recent progress and challenges in IDE-targeted therapies for T2D and AD.

PHARMACEUTICAL RESEARCH (2022)

Article Clinical Neurology

The impact of diabetes on cognitive impairment and its progression to dementia

Abigail Dove et al.

Summary: The study found that poorly controlled diabetes or diabetes with cardiovascular complications is associated with a higher risk of developing and progressing cognitive impairment. Inflammation may play a role in these relationships.

ALZHEIMERS & DEMENTIA (2021)

Review Biochemistry & Molecular Biology

Tau aggregation and its relation to selected forms of neuronal cell death

Aviva M. Tolkovsky et al.

Summary: The mechanism of neuronal cell death in neurodegenerative diseases, particularly in tauopathies, remains unclear. Multiple cell death pathways have been identified, including the contribution of tau aggregation and microglial phagocytosis of neurons with tau aggregates. Additional research is needed to further understand the complex process of cell death in these diseases.

MOLECULAR MECHANISMS OF NEURODEGENERATION (2021)

Review Nutrition & Dietetics

Oral administration of mangiferin ameliorates diabetes in animal models: a meta-analysis and systematic review

You Wu et al.

Summary: The meta-analysis shows that oral administration of mangiferin has a significant anti-diabetic effect in animal models, potentially attributed to its anti-inflammatory and antioxidative properties, as well as its role in improving glycolipid metabolism and enhancing insulin signaling.

NUTRITION RESEARCH (2021)

Review Clinical Neurology

Tau Post-translational Modifications: Dynamic Transformers of Tau Function, Degradation, and Aggregation

Carolina Alquezar et al.

Summary: Post-translational modifications play a crucial role in regulating tau protein function, including phosphorylation and acetylation. While these modifications may regulate protein function under normal conditions, they can be hijacked in disease states. Limited understanding exists on how these modifications impact tau protein, but studies indicate their critical role in localization, interactions, and other aspects.

FRONTIERS IN NEUROLOGY (2021)

Article Multidisciplinary Sciences

Association of metformin use with Alzheimer's disease in patients with newly diagnosed type 2 diabetes: a population-based nested case-control study

Junghee Ha et al.

Summary: Based on a retrospective study, treatment with metformin is associated with an increased risk of AD, especially in patients with longer duration of diabetes and comorbid depression. A double-blinded, prospective study is needed to determine the long-term cognitive safety of metformin, considering the large number of patients worldwide taking this medication.

SCIENTIFIC REPORTS (2021)

Article Geriatrics & Gerontology

Insulin-Like Growth Factor-1 Differentially Modulates Glutamate-Induced Toxicity and Stress in Cells of the Neurogliovascular Unit

Cellas A. Hayes et al.

Summary: The reduction of IGF-1 in aging is associated with increased risk of stroke and neurodegenerative diseases. IGF-1 promotes neuronal survival by acting directly on neurons and indirectly on astrocytes, indicating the importance of maintaining IGF-1 levels for the health of the entire neuro-glio-vascular unit.

FRONTIERS IN AGING NEUROSCIENCE (2021)

Review Neurosciences

The role of pathological tau in synaptic dysfunction in Alzheimer's diseases

Moxin Wu et al.

Summary: Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive cognitive decline, with synaptic dysfunction recognized as the main cause of cognitive impairments. Pathological tau is suggested to induce synaptic dysfunction in various ways, contributing to cognitive decline in AD. Exploring the mechanism by which pathological tau impairs synaptic function is crucial for developing novel therapeutic strategies for AD.

TRANSLATIONAL NEURODEGENERATION (2021)

Article Medicine, General & Internal

Association Between Age at Diabetes Onset and Subsequent Risk of Dementia

Claudio Barbiellini Amidei et al.

Summary: Younger age at onset of type 2 diabetes is significantly associated with a higher risk of subsequent dementia, indicating a graded association between age at onset of type 2 diabetes and dementia.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Review Medicine, General & Internal

Brain Glucose Metabolism in Health, Obesity, and Cognitive Decline-Does Insulin Have Anything to Do with It? A Narrative Review

Eleni Rebelos et al.

Summary: Using [F-18]-FDG-PET to image brain glucose metabolism has been a valuable tool in diagnosing cognitive disorders like Alzheimer's disease, with recent studies revealing connections between obesity, diabetes, and alterations in brain glucose metabolism. Understanding whether changes in brain glucose metabolism are a key determinant in the pathophysiology of metabolic and neurologic disorders is crucial for advancing research in this field.

JOURNAL OF CLINICAL MEDICINE (2021)

Review Cell Biology

Insulin Resistance and Diabetes Mellitus in Alzheimer's Disease

Jesus Burillo et al.

Summary: This review examines the main molecular mechanisms that may be involved in the connection between type 2 diabetes and neurodegenerative diseases, with a focus on inflammation, endoplasmic reticulum stress, autophagy, and mitochondrial dysfunction.
Article Clinical Neurology

Differential effects of risk factors on the cognitive trajectory of early- and late-onset Alzheimer's disease

Jaeho Kim et al.

Summary: Known risk factors for AD were associated with slower cognitive decline in EOAD but rapid cognitive decline in LOAD.

ALZHEIMERS RESEARCH & THERAPY (2021)

Review Geriatrics & Gerontology

Cholesterol and Alzheimer's Disease; From Risk Genes to Pathological Effects

Femke M. Feringa et al.

Summary: The brain tightly regulates cholesterol levels for physiological function, but excessive accumulation may contribute to Alzheimer's disease. Genetic risk factors associated with cholesterol metabolism may impact AD pathology. Advances in CRISPR/Cas9 gene editing and iPSC technology hold promise for further understanding these mechanisms.

FRONTIERS IN AGING NEUROSCIENCE (2021)

Review Cell Biology

Possible Mechanisms of Tau Spread and Toxicity in Alzheimer's Disease

Huiqin Zhang et al.

Summary: Tau protein binds to microtubules to promote assembly and stability, but loses this ability in tauopathies, leading to pathological changes like AD. Evidence suggests that tauopathies can spread between cells or connected regions. The complex process involves multiple steps including secretion, cellular uptake, transcellular transfer, and seeding, but the exact mechanisms of tau pathology propagation remain unclear.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Medicine, General & Internal

Association of Alzheimer's Disease and Insulin Resistance in King Abdulaziz Medical City, Jeddah

Norah T. Faqih et al.

Summary: The study found a significant association between Alzheimer's disease (AD) and insulin resistance (IR), with IR patients having a higher likelihood of developing AD. This association may be confounded by patient-related factors.

CUREUS JOURNAL OF MEDICAL SCIENCE (2021)

Review Biochemistry & Molecular Biology

Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease

Huiqin Zhang et al.

Summary: Extracellular neuritic plaques and intracellular neurofibrillary tangles, composed of amyloid-beta and phosphorylated tau protein respectively, are hallmark proteins of Alzheimer's disease. The interactions between these proteins have been extensively studied, with A beta accelerating tau phosphorylation, tau mediating A beta toxicity, and potential synergistic effects on microglial cells and astrocytes. Understanding these interactions may lead to new interventions against Alzheimer's disease.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

Article Clinical Neurology

Type 2 Diabetes Interacts With Alzheimer Disease Risk Factors to Predict Functional Decline

Kelsey R. Thomas et al.

ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2020)

Review Endocrinology & Metabolism

Metabolism: A Novel Shared Link between Diabetes Mellitus and Alzheimer's Disease

Yanan Sun et al.

JOURNAL OF DIABETES RESEARCH (2020)

Review Neurosciences

Neurodegenerative Diseases - Is Metabolic Deficiency the Root Cause?

Vignayanandam Ravindernath Muddapu et al.

FRONTIERS IN NEUROSCIENCE (2020)

Article Endocrinology & Metabolism

Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysis

Jian-Bo Zhou et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2020)

Article Biochemistry & Molecular Biology

Effect of Acupuncture on the p38 Signaling Pathway in Several Nervous System Diseases: A Systematic Review

Tzu-Hsuan Wei et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Biochemistry & Molecular Biology

Involvement of p38 MAPK in Synaptic Function and Dysfunction

Chiara Falcicchia et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Physiology

Glucose transporters in brain in health and disease

Hermann Koepsell

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2020)

Article Geriatrics & Gerontology

Antidiabetic Drugs for the Risk of Alzheimer Disease in Patients With Type 2 DM Using FAERS

Hayato Akimoto et al.

AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS (2020)

Review Neurosciences

The Link Between Tau and Insulin Signaling: Implications for Alzheimer's Disease and Other Tauopathies

Rafaella Araujo Goncalves et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2019)

Review Neurosciences

Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer's disease

Ramsey Najm et al.

MOLECULAR NEURODEGENERATION (2019)

Review Clinical Neurology

Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies

Yu Yamazaki et al.

NATURE REVIEWS NEUROLOGY (2019)

Article Neurosciences

Type-2-Diabetes Alters CSF but Not Plasma Metabolomic and AD Risk Profiles in Vervet Monkeys

Kylie Kavanagh et al.

FRONTIERS IN NEUROSCIENCE (2019)

Review Biochemistry & Molecular Biology

Alzheimer Disease: An Update on Pathobiology and Treatment Strategies

Justin M. Long et al.

Review Medicine, Research & Experimental

In vitro and in vivo evidence that quercetin protects against diabetes and its complications: A systematic review of the literature

Guang-Jiang Shi et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Review Cell Biology

Alzheimer's disease: risk factors and potentially protective measures

Marcos Vinicius Ferreira Silva et al.

JOURNAL OF BIOMEDICAL SCIENCE (2019)

Review Behavioral Sciences

Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link

Ying Zhang et al.

BEHAVIOURAL BRAIN RESEARCH (2018)

Article Cell & Tissue Engineering

Human Hippocampal Neurogenesis Persists throughout Aging

Maura Boldrini et al.

CELL STEM CELL (2018)

Review Chemistry, Medicinal

A comprehensive review on xanthone derivatives as α-glucosidase inhibitors

Clementina M. M. Santos et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Review Biochemistry & Molecular Biology

Type 2 Diabetes Mellitus and Alzheimer's Disease: Role of Insulin Signalling and Therapeutic Implications

Andrea Tumminia et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Article Multidisciplinary Sciences

Calpain-mediated tau fragmentation is altered in Alzheimer's disease progression

Hsu-Hsin Chen et al.

SCIENTIFIC REPORTS (2018)

Article Biochemistry & Molecular Biology

alpha-Glucosidase inhibition by flavonoids: an in vitro and in silico structure-activity relationship study

Carina Proenca et al.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)

Article Geriatrics & Gerontology

Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer's Disease

Roger J. Mullins et al.

FRONTIERS IN AGING NEUROSCIENCE (2017)

Article Neurosciences

ApoE isoforms differentially regulates cleavage and secretion of BDNF

Abhik Sen et al.

MOLECULAR BRAIN (2017)

Article Multidisciplinary Sciences

Resveratrol induces dephosphorylation of Tau by interfering with the MID1-PP2A complex

Susann Schweiger et al.

SCIENTIFIC REPORTS (2017)

Review Biochemistry & Molecular Biology

Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal

Ramesh Kandimalla et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)

Article Endocrinology & Metabolism

Efficacy of acarbose and metformin in newly diagnosed type 2 diabetes patients stratified by HbA1c levels

Jin-Ping Zhang et al.

JOURNAL OF DIABETES (2016)

Article Neurosciences

Human Truncated Tau Induces Mature Neurofibrillary Pathology in a Mouse Model of Human Tauopathy

Ivana Zimova et al.

JOURNAL OF ALZHEIMERS DISEASE (2016)

Review Immunology

Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?

Molly Stanley et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2016)

Article Endocrinology & Metabolism

Effects of Glucose and Insulin on Secretion of Amyloid-β by Human Adipose Tissue Cells

William G. Tharp et al.

OBESITY (2016)

Article Medicine, Research & Experimental

Hyperglycemia modulates extracellular amyloid-β concentrations and neuronal activity in vivo

Shannon L. Macauley et al.

JOURNAL OF CLINICAL INVESTIGATION (2015)

Review Clinical Neurology

Neuroinflammation in Alzheimer's disease

Michael T. Heneka et al.

LANCET NEUROLOGY (2015)

Article Biochemistry & Molecular Biology

Insulin therapy modulates mitochondrial dynamics and biogenesis, autophagy and tau protein phosphorylation in the brain of type 1 diabetic rats

R. X. Santos et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)

Article Clinical Neurology

APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis

Kristiina Rannikmaee et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)

Article Geriatrics & Gerontology

Impaired glycemia increases disease progression in mild cognitive impairment

Jill K. Morris et al.

NEUROBIOLOGY OF AGING (2014)

Review Neurosciences

ApoE and Aβ in Alzheimer's Disease: Accidental Encounters or Partners?

Takahisa Kanekiyo et al.

NEURON (2014)

Article Multidisciplinary Sciences

Diabetes Mellitus and the Risk of Alzheimer's Disease: A Nationwide Population-Based Study

Chin-Chou Huang et al.

PLOS ONE (2014)

Review Neurosciences

Insulin dysfunction and Tau pathology

Noura B. El Khoury et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2014)

Article Endocrinology & Metabolism

Brain Aging and AD-Like Pathology in Streptozotocin-Induced Diabetic Rats

Jian-Qin Wang et al.

JOURNAL OF DIABETES RESEARCH (2014)

Article Biochemistry & Molecular Biology

Dynamics of Hippocampal Neurogenesis in Adult Humans

Kirsty L. Spalding et al.

Article Biochemical Research Methods

Neuron Enriched Nuclear Proteome Isolated from Human Brain

Eric B. Dammer et al.

JOURNAL OF PROTEOME RESEARCH (2013)

Review Clinical Neurology

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

Chia-Chan Liu et al.

NATURE REVIEWS NEUROLOGY (2013)

Article Medicine, General & Internal

Glucose Levels and Risk of Dementia

Paul K. Crane et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Multidisciplinary Sciences

High Glucose Promotes Aβ Production by Inhibiting APP Degradation

Yi Yang et al.

PLOS ONE (2013)

Article Clinical Neurology

Central Obesity in the Elderly is Related to Late-onset Alzheimer Disease

Jose A. Luchsinger et al.

ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2012)

Article Biochemistry & Molecular Biology

Apolipoprotein E3 (ApoE3) but Not ApoE4 Protects against Synaptic Loss through Increased Expression of Protein Kinase Cε

Abhik Sen et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2012)

Article Multidisciplinary Sciences

Apolipoprotein E controls cerebrovascular integrity via cyclophilin A

Robert D. Bell et al.

NATURE (2012)

Article Developmental Biology

ApoE is required for maintenance of the dentate gyrus neural progenitor pool

Cui-Ping Yang et al.

DEVELOPMENT (2011)

Article Clinical Neurology

Truncation of tau at E391 Promotes Early Pathologic Changes in Transgenic Mice

Pamela J. McMillan et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)

Review Neurosciences

Adult hippocampal neurogenesis and its role in Alzheimer's disease

Yangling Mu et al.

MOLECULAR NEURODEGENERATION (2011)

Review Biochemistry & Molecular Biology

Post-translational modifications of tau protein: Implications for Alzheimer's disease

Ludovic Martin et al.

NEUROCHEMISTRY INTERNATIONAL (2011)

Article Multidisciplinary Sciences

Implicating Calpain in Tau-Mediated Toxicity In Vivo

James B. Reinecke et al.

PLOS ONE (2011)

Article Clinical Neurology

Variants at APOE Influence Risk of Deep and Lobar Intracerebral Hemorrhage

Alessandro Biffi et al.

ANNALS OF NEUROLOGY (2010)

Article Neurosciences

Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice

Corinne G. Jolivalt et al.

EXPERIMENTAL NEUROLOGY (2010)

Article Biochemistry & Molecular Biology

Phosphorylation of Tau at Thr212, Thr231, and Ser262 Combined Causes Neurodegeneration

Alejandra D. Alonso et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Editorial Material Multidisciplinary Sciences

Linking type 2 diabetes and Alzheimer's disease

Weiping Han et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Multidisciplinary Sciences

ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling

Ying Chen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Neurosciences

ApoE4 Decreases Spine Density and Dendritic Complexity in Cortical Neurons In Vivo

Sonya B. Dumanis et al.

JOURNAL OF NEUROSCIENCE (2009)

Article Neurosciences

Characterizing the Appearance and Growth of Amyloid Plaques in APP/PS1 Mice

Ping Yan et al.

JOURNAL OF NEUROSCIENCE (2009)

Review Neurosciences

Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms

Emmanuel Planel et al.

JOURNAL OF NEUROSCIENCE (2007)

Article Biochemistry & Molecular Biology

Soluble Aβ inhibits specific signal transduction cascades common to the insulin receptor pathway

Matthew Townsend et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

Article Endocrinology & Metabolism

Alzheimer-like changes in rat models of spontaneous diabetes

Zhen-guo Li et al.

DIABETES (2007)

Article Multidisciplinary Sciences

Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model

Y. P. Wang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Endocrinology & Metabolism

Low-dose acarbose does not delay digestion of starch but reduces its bioavailability

R. E. Wachters-Hagedoorn et al.

DIABETIC MEDICINE (2007)

Article Endocrinology & Metabolism

The effect of borderline diabetes on the risk of dementia and Alzheimer's disease

Weili Xu et al.

DIABETES (2007)

Article Biochemistry & Molecular Biology

Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo

Norbert Zilka et al.

FEBS LETTERS (2006)

Article Biochemistry & Molecular Biology

C-terminal truncation modulates both nucleation and extension phases of τ fibrillization

HS Yin et al.

FEBS LETTERS (2006)

Article Biochemistry & Molecular Biology

APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response

JR Lynch et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2003)

Article Biotechnology & Applied Microbiology

Alzheimer's missing link?

[Anonymous]

MOLECULAR THERAPY (2003)

Article Multidisciplinary Sciences

Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease

TC Gamblin et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Article Multidisciplinary Sciences

Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo

W Farris et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Article Biochemistry & Molecular Biology

Apolipoprotein E and apolipoprotein E receptors modulate Aβ-induced glial neuroinflammatory responses

MJ LaDu et al.

NEUROCHEMISTRY INTERNATIONAL (2001)